We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Target prices reflect the market consensus (mean/high/low), not individual research firms. 4 actions collected · 4 in the last 12 months.
Auto-generated summary combining US and Korean research and earnings · not investment advice
Samsung Life recorded Earnings Per Share (EPS) of 6,702 won in Q1 2026, a significant increase from the previous quarter. Revenue has consistently maintained the early 2 trillion won range in recent quarters. However, analyst consensus target prices and detailed valuation information are unavailable. All domestic securities firms have only issued 'Hold' recommendations, indicating a lack of specific information regarding new investment directions.
Divergence: There is no divergence of opinion between US and Korean analysts, and domestic securities firms have all issued 'Hold' ratings, but specific target prices or rating details were not provided, making it difficult to ascertain a clear direction.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 07. 20. | 한화투자증권 | — | Maintain | — → — | — | 연결 자회사의 실적 호조를 기대 |
| 2026. 07. 14. | iM증권 | — | Maintain | — → — | — | 본업보다는 전자 지분과 계열사가 핵심 |
| 2026. 06. 22. | 대신증권 | — | Maintain | — → — | — | 새로운 가치평가 방식 필요 |
| 2026. 06. 11. | 한화투자증권 | — | Maintain | — → — | — | 근거가 부족한 NAV 할인율의 축소 |